Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending May 11, 2024 (Week 19) column labels (in same order that data fields appears in each record below): Reporting Area Carbapenemase-Producing Organisms (CPO), Total §; Current week Carbapenemase-Producing Organisms (CPO), Total §; Previous 52 weeks Max + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2024 + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2023 + tab delimited data: U.S. Residents, excluding U.S. Territories 35 NC 1,249 2,451 New England 2 NC 20 21 Connecticut - NC - - Maine - NC - - Massachusetts - NC - - New Hampshire - NC 7 8 Rhode Island 2 NC 13 13 Vermont - NC - - Middle Atlantic 5 NC 49 278 New Jersey - NC - - New York (excluding New York City) - NC - - New York City - NC - 77 Pennsylvania 5 NC 49 201 East North Central 17 NC 783 589 Illinois - NC - 2 Indiana - NC 84 142 Michigan - NC 39 98 Ohio 17 NC 660 328 Wisconsin - NC - 19 West North Central - NC 34 60 Iowa - NC - 28 Kansas - NC 34 30 Minnesota - NC - - Missouri - NC - - Nebraska - NC - - North Dakota - NC - 2 South Dakota - NC - - South Atlantic - NC 46 273 Delaware - NC - 3 District of Columbia - NC - - Florida N NC N N Georgia - NC - 103 Maryland - NC - - North Carolina - NC - 55 South Carolina - NC - - Virginia - NC - 92 West Virginia - NC 46 20 East South Central - NC - 44 Alabama N NC N N Kentucky - NC - - Mississippi - NC - 44 Tennessee - NC - - West South Central - NC - 8 Arkansas - NC - - Louisiana - NC - 8 Oklahoma - NC - - Texas - NC - - Mountain 11 NC 317 275 Arizona 11 NC 308 264 Colorado - NC - - Idaho - NC - - Montana - NC - - Nevada - NC 1 4 New Mexico - NC - - Utah - NC 8 6 Wyoming - NC - 1 Pacific - NC - 903 Alaska - NC - - California - NC - 893 Hawaii - NC - 5 Oregon - NC - 1 Washington - NC - 4 U.S. Territories - NC - 20 American Samoa - NC - - Commonwealth of Northern Mariana Islands - NC - - Guam - NC - - Puerto Rico - NC - 20 U.S. Virgin Islands - NC - - Non-U.S. Residents - NC - - Total 35 NC 1,249 2,471 U: Unavailable - The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases - The reporting jurisdiction did not submit any cases to CDC. N: Not reportable - The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable - This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published. NC: Not calculated - There is insufficient data available to support the calculation of this statistic. Cum: Cumulative year-to-date counts. * Case counts for reporting years 2023 and 2024 are provisional and subject to change. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/ § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.